000 | 01934 a2200529 4500 | ||
---|---|---|---|
005 | 20250516210248.0 | ||
264 | 0 | _c20141204 | |
008 | 201412s 0 0 eng d | ||
022 | _a1549-4713 | ||
024 | 7 |
_a10.1016/j.ophtha.2014.03.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSun, Catherine Q | |
245 | 0 | 0 |
_aAssociation between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis. _h[electronic resource] |
260 |
_bOphthalmology _cAug 2014 |
||
300 |
_a1495-500.e1 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdministration, Topical |
650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
650 | 0 | 4 |
_aCicatrix _xpathology |
650 | 0 | 4 |
_aCorneal Perforation _xdiagnosis |
650 | 0 | 4 |
_aCorneal Ulcer _xdrug therapy |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aEpithelium, Corneal _xphysiology |
650 | 0 | 4 |
_aEye Infections, Fungal _xdrug therapy |
650 | 0 | 4 |
_aFungi _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKeratoplasty, Penetrating |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aNatamycin _xpharmacology |
650 | 0 | 4 | _aOphthalmic Solutions |
650 | 0 | 4 | _aRe-Epithelialization |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
650 | 0 | 4 |
_aVoriconazole _xpharmacology |
700 | 1 | _aLalitha, Prajna | |
700 | 1 | _aPrajna, N Venkatesh | |
700 | 1 | _aKarpagam, Rajarathinam | |
700 | 1 | _aGeetha, Manoharan | |
700 | 1 | _aO'Brien, Kieran S | |
700 | 1 | _aOldenburg, Catherine E | |
700 | 1 | _aRay, Kathryn J | |
700 | 1 | _aMcLeod, Stephen D | |
700 | 1 | _aAcharya, Nisha R | |
700 | 1 | _aLietman, Thomas M | |
773 | 0 |
_tOphthalmology _gvol. 121 _gno. 8 _gp. 1495-500.e1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ophtha.2014.03.004 _zAvailable from publisher's website |
999 |
_c23750386 _d23750386 |